Organogenesis ORGO 深 滬
等待開盤 07-24 09:30:00 美东时间
2.43
-0.040
-1.62%
華盛通- 最 高2.48
- 今 開2.45
- 成交量 77.42万股
- 最 低 2.345
- 昨 收 2.47
- 總市值 3.13亿
- 52周最高 7.0771
- 市盈率 靜 15.81
- 換手率 0.00%
- 52周最低 2.04
- 委 比 -69.86%
- 總股本 1.29亿
- 歷史最高 310.90
- 量 比 1.27
- 振 幅 5.47%
- 歷史最低 1.795
- 每 手 1
- 風險率 1.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 1% on Tuesday. Shares of Danaher Corp (NYSE:DHR) fell sharply in pre-market trading following second-quarter results. Danaher posted second-quarter adjusted EPS of $1.94, beating market estimates of $1.83. The...
07-21 20:01
Organogenesis' Biologics License Application For ReNu Receives FDA's Acceptance For Review To Treat Pain In Symptomatic Knee Osteoarthritis
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that the U.S. Food and Drug Administration (FDA) has completed their filing determination and accepte...
07-07 04:06
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
Organogenesis Holdings Inc. announced that the FDA has accepted its Biologics License Application (BLA) for ReNu®, a cryopreserved amniotic suspension allograft for treating knee osteoarthritis pain, with a PDUFA target action date set for April 24, 2027. ReNu® has been studied in three large RCTs involving over 1,300 patients and received FDA RMAT designation in 2021. The company aims to bring the first non-surgical biologic therapy to millions ...
07-06 20:05
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
Deckers Outdoor, UP Fintech And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures rise with Dow gaining 300 points. Deckers Outdoor Corp shares fall after beating Q4 revenue estimates and providing fiscal 2027 guidance.
05-22 20:38
Organogenesis Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results and cut its FY26 sales guidance below estimates.
Organogenesis Holdings shares are trading lower after the company reported wors...
05-08 19:59
What's Going On With Organogenesis Stock On Wednesday?
Organogenesis stock rises after PuraPly AM trial shows improved diabetic foot ulcer closure; RSI signals oversold levels amid weak trend.
04-08 22:15
美股夜盘 | Mawson Infrastructure Group Inc涨40.15%，Organogenesis Holdings, Inc. Class A涨29.46%
Mawson Infrastructure Group Inc涨40.15%；Organogenesis Holdings, Inc. Class A涨29.46%；Alignment Healthcare, Inc.涨15.85%
04-07 15:01
美股夜盘 | Mawson Infrastructure Group Inc涨42.86%，Organogenesis Holdings, Inc. Class A涨20.54%
Mawson Infrastructure Group Inc涨42.86%；Organogenesis Holdings, Inc. Class A涨20.54%；Alignment Healthcare, Inc.涨15.85%
04-07 13:01
美股夜盘 | Mawson Infrastructure Group Inc涨42.86%，Organogenesis Holdings, Inc. Class A涨18.75%
Mawson Infrastructure Group Inc涨42.86%；Organogenesis Holdings, Inc. Class A涨18.75%；Alignment Healthcare, Inc.涨15.85%
04-07 10:01
